Evidence map›Paper›PMID 23262747›Full record

ArticleWiener klinische Wochenschrift2012

[Diabetic nephropathy--update 2012].

Martin Auinger, Roland Edlinger, Friedrich Prischl, Alexandra Kautzky-Willer, Rudolf Prager, Alexander R Rosenkranz, Michael Roden, Marcus Saemann, Martin Clodi, Guntram Schernthaner

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. [Diabetic kidney disease - Update 2016].Wiener klinische Wochenschrift · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Martin Auinger3. Medizinische Abteilung, Krankenhaus Hietzing der Stadt Wien, und Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Wien, Österreich. martin.auinger@wienkav.at
Roland Edlinger
Friedrich Prischl
Alexandra Kautzky-Willer
Rudolf Prager
Alexander R Rosenkranz
Michael Roden
Marcus Saemann
Martin Clodi
Guntram Schernthaner

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is the leading single cause for renal replacement therapy. Its development and progression, however, can be ameliorated by adequate therapy. The present article represents the recommendations of the Austrian Diabetes Association and the Austrian Society for Nephrology for the prevention and treatment of diabetic nephropathy.

Indexed as

Practice Guidelines as TopicAustriaDiabetic NephropathiesHumansRenal Replacement Therapy

Identifiers

PMID23262747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.